Microdissection of cancer-associated fibroblast infiltration subtypes unveils the secreted SERPINE2 contributing to immunosuppressive microenvironment and immuotherapeutic resistance in gastric cancer: A large-scale study integrating bulk and single-cell transcriptome profiling

[1]  Guo Ci Teo,et al.  Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. , 2022, Cancer cell.

[2]  C. Li,et al.  Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment , 2022, Nature Communications.

[3]  Chang Liu,et al.  Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer , 2022, Frontiers in Immunology.

[4]  Qiang Sun,et al.  Novel insight into the role of immunotherapy in gastrointestinal cancer (Review) , 2022, Molecular and clinical oncology.

[5]  Q. Tang,et al.  Immunotherapy-based novel nanoparticles in the treatment of gastrointestinal cancer: Trends and challenges , 2022, World journal of gastroenterology.

[6]  Midie Xu,et al.  The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer , 2022, Cell Death & Disease.

[7]  V. Adam,et al.  Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape , 2022, Journal of Hematology & Oncology.

[8]  F. Zhou,et al.  Single-cell transcriptomics reveals a low CD8+ T cell infiltrating state mediated by fibroblasts in recurrent renal cell carcinoma , 2022, Journal for ImmunoTherapy of Cancer.

[9]  Weidong Wei,et al.  Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer , 2022, Oncoimmunology.

[10]  R. Zhao,et al.  Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer , 2022, Theranostics.

[11]  Jianwen Hu,et al.  CAF promotes chemoresistance through NRP2 in gastric cancer , 2021, Gastric Cancer.

[12]  M. Karamouzis,et al.  Immunotherapy for gastric cancer: a 2021 update. , 2021, Immunotherapy.

[13]  M. Teh,et al.  Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer , 2021, Cancer discovery.

[14]  Xueqin Chen,et al.  SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer. , 2021, Cancer letters.

[15]  Hang Zheng,et al.  Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer , 2021, Frontiers in Molecular Biosciences.

[16]  R. Kalluri,et al.  Clinical and therapeutic relevance of cancer-associated fibroblasts , 2021, Nature Reviews Clinical Oncology.

[17]  Stephen R. Williams,et al.  A single-cell and spatially resolved atlas of human breast cancers , 2021, Nature Genetics.

[18]  Dana R. Valley,et al.  Proteogenomic characterization of pancreatic ductal adenocarcinoma , 2021, Cell.

[19]  C. Proud,et al.  MRTF-A-NF-κB/p65 axis-mediated PDL1 transcription and expression contributes to immune evasion of non-small-cell lung cancer via TGF-β , 2021, Experimental & Molecular Medicine.

[20]  Linda T. Nieman,et al.  Spatially organized multicellular immune hubs in human colorectal cancer , 2021, Cell.

[21]  Lianmei Zhao,et al.  Advances in clinical immunotherapy for gastric cancer. , 2021, Biochimica et biophysica acta. Reviews on cancer.

[22]  Dana R. Valley,et al.  A proteogenomic portrait of lung squamous cell carcinoma , 2021, Cell.

[23]  Yongyong Shi,et al.  Integrative omics analysis reveals effective stratification and potential prognosis markers of pan-gastrointestinal cancers , 2021, iScience.

[24]  N. Almog,et al.  Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. , 2021, Cancer cell.

[25]  H. Martinson,et al.  Recent Advances in Immune Therapies for Gastric Cancer , 2021, Cancer Gene Therapy.

[26]  Qifeng Yang,et al.  Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28 , 2021, Theranostics.

[27]  M. Pevsner-Fischer,et al.  Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles , 2021, Cancer Research.

[28]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[29]  S. Chouaib,et al.  Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies , 2021, Frontiers in Immunology.

[30]  Alexander R. Pico,et al.  Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. , 2021, Cancer cell.

[31]  Jun Xie,et al.  Immunotherapy of gastric cancer: Past, future perspective and challenges. , 2020, Pathology, research and practice.

[32]  Yang Liu,et al.  BAP31 Promotes Tumor Cell Proliferation by Stabilizing SERPINE2 in Hepatocellular Carcinoma , 2020, Frontiers in Cell and Developmental Biology.

[33]  P. Bose,et al.  TGF-β Mediated Immune Evasion in Cancer—Spotlight on Cancer-Associated Fibroblasts , 2020, Cancers.

[34]  Jeffrey R. Whiteaker,et al.  Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy , 2020, Cell.

[35]  I. Barshack,et al.  Fibroblast-Derived IL33 Facilitates Breast Cancer Metastasis by Modifying the Immune Microenvironment and Driving Type 2 Immunity , 2020, Cancer Research.

[36]  Fan Zhang,et al.  TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment , 2020, bioRxiv.

[37]  X. Liu,et al.  Stromal cell diversity associated with immune evasion in human triple‐negative breast cancer , 2020, The EMBO journal.

[38]  Hiroki Sato,et al.  High expression level of serpin peptidase inhibitor clade E member 2 is associated with poor prognosis in lung adenocarcinoma , 2020, Respiratory Research.

[39]  H. Grabsch,et al.  Gastric cancer , 2020, The Lancet.

[40]  Jeffrey R. Whiteaker,et al.  Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma , 2020, Cell.

[41]  Shuofeng Hu,et al.  Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing , 2020, Gut.

[42]  Angela N. Brooks,et al.  Visualizing and interpreting cancer genomics data via the Xena platform , 2020, Nature Biotechnology.

[43]  Y. Huh,et al.  Deconvolution of diffuse gastric cancer and the suppression of CD34 on the BALB/c nude mice model , 2020, BMC Cancer.

[44]  Peter B. McGarvey,et al.  Proteogenomic Characterization of Endometrial Carcinoma , 2020, Cell.

[45]  V. Pillarisetty,et al.  The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. , 2019, Seminars in cancer biology.

[46]  Zhihua Liu,et al.  SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4. , 2019, Cancer letters.

[47]  David L. Marron,et al.  B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer , 2019, Cell.

[48]  Jian Ren Gu,et al.  Lysyl oxidase promotes liver metastasis of gastric cancer via facilitating the reciprocal interactions between tumor cells and cancer associated fibroblasts , 2019, EBioMedicine.

[49]  K. Zen,et al.  Protease Nexin I is a feedback regulator of EGF/PKC/MAPK/EGR1 signaling in breast cancer cells metastasis and stemness , 2019, Cell Death & Disease.

[50]  Yifen Zhang,et al.  Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer. , 2019, Cancer letters.

[51]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[52]  Subha Madhavan,et al.  Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities , 2019, Cell.

[53]  Fan Zhang,et al.  Fast, sensitive, and accurate integration of single cell data with Harmony , 2018, bioRxiv.

[54]  E. Song,et al.  Turning foes to friends: targeting cancer-associated fibroblasts , 2018, Nature Reviews Drug Discovery.

[55]  Yassen Assenov,et al.  Maftools: efficient and comprehensive analysis of somatic variants in cancer , 2018, Genome research.

[56]  X. Liu,et al.  Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response , 2018, Nature Medicine.

[57]  Hong Yang,et al.  Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Gastrointestinal Pan-Adenocarcinomas , 2018, EBioMedicine.

[58]  Joon-Oh Park,et al.  Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer , 2018, Nature Medicine.

[59]  Zev J. Gartner,et al.  DoubletFinder: Doublet detection in single-cell RNA sequencing data using artificial nearest neighbors , 2018, bioRxiv.

[60]  G. Mills,et al.  Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype , 2018, Nature Communications.

[61]  Michael T. Zimmermann,et al.  Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas , 2018, Cell reports.

[62]  Xing Fu,et al.  Expression pattern of human SERPINE2 in a variety of human tumors. , 2018, Oncology letters.

[63]  Steven J. M. Jones,et al.  The Immune Landscape of Cancer , 2018, Immunity.

[64]  Shelly Maman,et al.  A history of exploring cancer in context , 2018, Nature Reviews Cancer.

[65]  R. Bourgon,et al.  TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells , 2018, Nature.

[66]  M. Ringnér,et al.  Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma , 2017, Nature Communications.

[67]  Yu Wang,et al.  Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data , 2017, Genome Medicine.

[68]  Jing Wang,et al.  LinkedOmics: analyzing multi-omics data within and across 32 cancer types , 2017, Nucleic Acids Res..

[69]  T. Chan,et al.  Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab , 2017, Cell.

[70]  Yuan Shen,et al.  SerpinE2, a poor biomarker of endometrial cancer, promotes the proliferation and mobility of EC cells. , 2017, Cancer biomarkers : section A of Disease markers.

[71]  Carla Oliveira,et al.  Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications , 2017, Pathobiology.

[72]  D. Speiser,et al.  Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data , 2017, bioRxiv.

[73]  J. Wargo,et al.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy , 2017, Cell.

[74]  T. Stępień,et al.  Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer , 2017, Disease markers.

[75]  I. Mellman,et al.  Elements of cancer immunity and the cancer–immune set point , 2017, Nature.

[76]  P. Carmeliet,et al.  Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy. , 2016, Cancer cell.

[77]  P. Laurent-Puig,et al.  Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression , 2016, Genome Biology.

[78]  R. Kalluri.  The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[79]  Wanchun Wang,et al.  SerpinE2 promotes multiple cell proliferation and drug resistance in osteosarcoma. , 2016, Molecular medicine reports.

[80]  Ronald J. Moore,et al.  Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer , 2016, Cell.

[81]  Pornpimol Charoentong,et al.  Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade , 2016, bioRxiv.

[82]  Na-Yu Chia,et al.  Molecular classification of gastric cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[83]  Michael L. Gatza,et al.  Proteogenomics connects somatic mutations to signaling in breast cancer , 2016, Nature.

[84]  K. Schalper,et al.  Epithelial–Mesenchymal Transition and Immune Evasion during Lung Cancer Progression: The Chicken or the Egg? , 2016, Clinical Cancer Research.

[85]  Gianluca Bontempi,et al.  TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data , 2015, Nucleic acids research.

[86]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[87]  Stephen T. C. Wong,et al.  EMT is not required for lung metastasis but contributes to chemoresistance , 2015, Nature.

[88]  Jaime Rodriguez-Canales,et al.  A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition , 2015, Clinical Cancer Research.

[89]  Y. Sakamoto,et al.  CXCL12/CXCR4 activation by cancer‐associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer , 2015, International journal of cancer.

[90]  A. Xing,et al.  Prognostic significance of SERPINE2 in gastric cancer and its biological function in SGC7901 cells , 2015, Journal of Cancer Research and Clinical Oncology.

[91]  Jason G. Jin,et al.  Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes , 2015, Nature Medicine.

[92]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[93]  C. Graham,et al.  Mechanisms of hypoxia-mediated immune escape in cancer. , 2014, Cancer research.

[94]  Shuqiong Fan,et al.  Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets , 2014, Genes, chromosomes & cancer.

[95]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.

[96]  H. Ng,et al.  Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development , 2014, Gut.

[97]  Insuk Sohn,et al.  Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery , 2014, PloS one.

[98]  R. S. Huang,et al.  Abstract 5561: Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines , 2014 .

[99]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[100]  P. Johnston,et al.  Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.

[101]  Mira Ayadi,et al.  Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value , 2013, PLoS medicine.

[102]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[103]  R. Muschel,et al.  Protease nexin 1: a novel regulator of prostate cancer cell growth and neo-angiogenesis , 2013, Oncotarget.

[104]  Günter P. Wagner,et al.  Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples , 2012, Theory in Biosciences.

[105]  S. Chouaib,et al.  Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape , 2012, Front. Immun..

[106]  Matthew N. McCall,et al.  Thawing Frozen Robust Multi-array Analysis (fRMA) , 2011, BMC Bioinformatics.

[107]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[108]  Jae Yong Cho,et al.  Gene Expression Signature–Based Prognostic Risk Score in Gastric Cancer , 2011, Clinical Cancer Research.

[109]  Drew A. Torigian,et al.  CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans , 2011, Science.

[110]  S. Cagnol,et al.  The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis , 2010, Molecular Cancer.

[111]  H. Zhang,et al.  Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers , 2010, Journal of experimental & clinical cancer research : CR.

[112]  Matthew D. Wilkerson,et al.  ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..

[113]  Y. Jo,et al.  SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer. , 2010, Biochemical and biophysical research communications.

[114]  Yanping Zhang,et al.  Tumor Microenvironments Direct the Recruitment and Expansion of Human Th17 Cells , 2009, The Journal of Immunology.

[115]  Hyun Cheol Chung,et al.  Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer , 2009, PLoS genetics.

[116]  C. V. D. Velde,et al.  Gastric cancer , 2009, The Lancet.

[117]  N. Hynes,et al.  The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression. , 2009, Cancer research.

[118]  C. Hsueh,et al.  Updates in Gastrointestinal Oncology – insights from the 2008 44th annual meeting of the American Society of Clinical Oncology , 2009, Journal of hematology & oncology.

[119]  Alessandro Giuliani,et al.  Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. , 2009, European journal of cancer.

[120]  R. Orlando,et al.  Protease nexin-1 expression is altered in human breast cancer , 2006, Cancer Cell International.

[121]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[122]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[123]  Takeshi Iwamura,et al.  SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo. , 2003, Cancer research.

[124]  M. Platten,et al.  Malignant glioma biology: Role for TGF‐β in growth, motility, angiogenesis, and immune escape , 2001 .

[125]  M. Löwer,et al.  Bioinformatics for Cancer Immunotherapy. , 2020, Methods in molecular biology.

[126]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .